| Filed On | Filing |
|---|---|
| 19 Feb 2021 | 424B3 |
| 08 Feb 2021 | 424B3 |
| 01 Dec 2020 | 424B3 |
| 24 Nov 2020 | 424B3 |
| 28 Oct 2020 | 424B3 |
| 21 Aug 2009 | FINAL PROSPECTUS FILED PURSUANT TO RULE 424(B)(3) |
| 18 Sep 2008 | 424B3 |
| 02 Aug 2007 | PROSPECTUS SUPPLEMENT NO. 5 |
| 22 May 2007 | PROSPECTUS SUPPLEMENT NO. 2 TO PROSPECTUS DATED JANUARY 26, 2005 |
| 22 May 2007 | PROSPECTUS SUPPLEMENT NO. 7 TO PROSPECTUS DATED MARCH 18, 2004 |
| 31 Aug 2006 | PROSPECTUS SUPPLEMENT NO. 6 |
| 31 Aug 2006 | PROSPECTUS SUPPLEMENT NO. 4 |
| 07 Jun 2006 | PROSPECTUS SUPPLEMENT NO. 5 TO PROSPECTUS DATED 03/18/04 |
| 30 Mar 2006 | PROSPECTUS SUPPLEMENT NO. 4 |
| 28 Feb 2006 | PROSPECTUS SUPPLEMENT NO. 3 |
| 07 Feb 2006 | SUPPLEMENT TO PROSPECTUS DATED MARCH 18, 2004 |
| 20 Dec 2005 | SUPPLEMENT NO. 2 TO PROSPECTUS DATED MARCH 2, 2004 |
| 20 Dec 2005 | SUPPLEMENT NO. 2 TO PROSPECTUS DATED MARCH 18, 2004 |
| 20 Dec 2005 | SUPPLEMENT NO. 1 TO PROSPECTUS DATED JANUARY 26, 2005 |
| 07 Feb 2005 | 424B3 FOR CORTEX PHARMACEUTICALS |
Loading...
